FilingReader Intelligence

Kehua Bio-Engineering receives medical device registration certificate

August 12, 2025 at 06:25 AM UTCBy FilingReader AI

Shanghai Kehua Bio-Engineering obtained a medical device registration certificate from the Shanghai Municipal Drug Administration for an in-vitro diagnostic reagent.

The newly registered product is a C-reactive protein assay kit intended for quantitative determination of CRP in human serum and plasma samples, aiding in auxiliary diagnosis of non-specific inflammation.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:002022Shenzhen Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Shanghai Kehua Bio-Engineering publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →